2G2-58037-43048
4 vaccinations
3 coded responses
39 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 940 / CA
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Moderna
-
2021-03-04
Registered in v-safe
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-05
- 2021-03-14
-
2021-03-19
Survey response — day 21, dose 1MedDRA: Injection site pruritus, Injection site reaction, Rash, Skin discolouration — Feeling: GoodFree text: Roughly oval patch of pink, slightly raised skin, with a darker perimeter. Around injection sight. Slightly itchy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Dose 2 — Moderna
-
2021-03-25
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness · Fever · Chills, Fatigue or tirednessAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-29
- 2021-05-06
- 2021-06-24
- 2021-09-23
-
2021-11-23
Dose 3 — Moderna
-
2021-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-02-22
-
2022-05-25
Survey response — 6 months, dose 3MedDRA: Cough, Fatigue, Oropharyngeal pain, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sore throat, fever, congestion, cough, fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-25
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-25
-
2022-10-12
Dose 4 — ModernaCo-administered: Flu
- 2022-11-01
- 2022-11-02
-
2022-11-09
Survey response — day 28, dose 4MedDRA: Body temperature increased, Chills — Feeling: GoodFree text: Thursday PM lowgrade fever 100F and chills. Spontaneous, no other symptoms.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-16
- 2022-11-23
- 2023-01-11
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Moderna | |
| 2 | 2021-03-25 | Moderna | |
| 3 | 2021-11-23 | Moderna | No |
| 4 | 2022-10-12 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-25 | Unsuccessful |
Free text
Release 5 — day 21, dose 1
Symptoms: Roughly oval patch of pink, slightly raised skin, with a darker perimeter. Around injection sight. Slightly itchy.
Release 11 — 6 months, dose 3
Symptoms: Sore throat, fever, congestion, cough, fatigue.
Release 12 — day 28, dose 4
Symptoms: Thursday PM lowgrade fever 100F and chills. Spontaneous, no other symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site reaction | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Skin discolouration | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release